Marc Grasso

Marc Grasso

No más puestos en curso

Fortuna: 447 069 $ al 31/07/2026

53 años
Finance
Health Technology
Consumer Services

Perfil

Marc Edward Grasso formerly worked at Morgan Stanley & Co. LLC, as Executive Director-Investment Banking, Leerink Partners LLC, as Managing Director from 2008 to 2010, Leerink Swann & Co., as Managing Director-Investment Banking from 2008 to 2010, Credit Suisse Securities (USA) LLC (Broker), as Vice President-Investment Banking, Stifel Financial Corp., as MD-Healthcare Investment Banking Group from 2013 to 2018, UBS Group AG, as MD-Investment Banking & Global Healthcare Group from 2010 to 2013, Kura Oncology, Inc., as Secretary, Chief Financial & Business Officer in 2019, Kyverna Therapeutics, Inc., as Chief Financial Officer & Accounting Officer from 2025 to 2026, and Alector, Inc., as Chief Financial Officer from 2022 to 2025.
Dr. Grasso received his undergraduate degree from Princeton University and doctorate degree from The Johns Hopkins University School of Medicine.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
02/06/2025 296.072 ( 0,27 % ) 447 069 $ 31/07/2026

Antiguos cargos conocidos de Marc Grasso.

EmpresasCargoFin
KYVERNA THERAPEUTICS, INC. Director Financiero/CFO 18/05/2026
ALECTOR, INC. Director Financiero/CFO 20/06/2025
KURA ONCOLOGY, INC. Director Financiero/CFO 04/02/2022
STIFEL FINANCIAL CORP. Corporate Officer/Principal 01/07/2018
UBS GROUP AG Corporate Officer/Principal 01/02/2013
Ver el detalle de la experiencia de Marc Grasso.

Formación de Marc Grasso.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

75

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Finance

Finance

Finance

Health Technology

Finance

Finance

Consumer Services

Health Technology

Consumer Services

Finance

Health Technology